HEALTHDAILY MAIL
Wonder pill shrinks tumours in a third of patients with six hard-to-treat cancers, early trial shows
An experimental 'wonder pill' reduced tumors in one-third of patients with six challenging-to-treat cancers, according to an early-stage clinical trial. The results suggest potential therapeutic promise for these aggressive cancer types.
Related Signal
Adjacent reporting
- New pancreatic cancer pill could reshape treatment as early trial results stun researchers
- Experimental pill promises new hope for deadly pancreatic cancer
- Experimental pill promises new hope for deadly pancreatic cancer
- Experimental pill promises new hope for deadly pancreatic cancer
- Experimental pill promises new hope for deadly pancreatic cancer
- Daily pill can double survival time for deadliest cancer, trial shows